Norimasa Kaneda - Concepedia

Author

Norimasa Kaneda

Yakult Central Institute

Also Known As

Norimasa KANEDA, Norimasa Kaneda

Publications

611

Citations

H-Index

Concepts

All Affiliations

Yakult Central Institute

About

Norimasa Kaneda is an author at Yakult Central Institute specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	507
2	Biochemistry	6	6	315
3	Natural Sciences	3	3	169
4	Engineering	1	1	10
5	Health Sciences	1	1	10

Norimasa Kaneda

Publications

583

Citations

H-Index

Page 1

	Year	Citations
CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties. Tatsuya Tsuji, Norimasa Kaneda, Kunio KADO, Journal of Pharmacobio-Dynamics Pharmaceutical ScienceExperimental PharmacologyPharmaceutical ChemistryProtein PurificationMedicinal Chemistry	1991	139
Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats Akinobu Kurita, Shoichi Kado, Norimasa Kaneda, Cancer Chemotherapy and Pharmacology Administration ScheduleMedicinePhysiologyGastroenterologyIrinotecan Hydrochloride	2000	99
High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT Akinobu Kurita, Norimasa Kaneda Journal of Chromatography B Biomedical Sciences and Applications BiochemistryBioassay-guided IsolationMedicineGas ChromatographyBioanalysis	1999	68
Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors Ryuta Yamazaki, Shinichi Kawai, Takeshi Matsuzaki, European Journal of Pharmacology BiosynthesisOxysterolBiochemistryMedicineE2 Production	1997	68
Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen Akinobu Kurita, Shoichi Kado, Tsuneo Matsumoto, Cancer Chemotherapy and Pharmacology Gastrointestinal PharmacologyMedicineGastroenterologyPathologyIntestinal Lumen	2010	63
Effects of CPT‐11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno‐transplanted neuroblastoma Hiroaki Komuro, Pai Li, Yoshiaki Tsuchida, Medical and Pediatric Oncology	1994	41
Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion Akinobu Kurita, Shoichi Kado, Norimasa Kaneda, Cancer Chemotherapy and Pharmacology Intravenous InfusionPharmacological StudyOxidative StressMedicineSide Effects	2003	27
Simultaneous Determination of the Lactone and Carboxylate Forms of 7-Ethyl-10 hydroxycamptothecin (SN-38), the Active Metabolite of Irinotecan (CPT-11), in Rat Plasma by High Performance Liquid Chromatography. Norimasa Kaneda, Yukiko HOSOKAWA, Teruo Yokokura Biological and Pharmaceutical Bulletin	1997	25
Synthesis, Characterization, and Preliminary in Vivo Tests of New Poly(ethylene glycol) Conjugates of the Antitumor Agent 10-Amino-7-ethylcamptothecin Andrea Guiotto, Mirta Canevari, Piero Orsolini, Journal of Medicinal Chemistry Ethylene GlycolBioorganic ChemistryNew PolyChemical BiologyPharmaceutical Chemistry	2004	20
Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats Masaharu Onoue, Akinobu Kurita, Shoichi Kado, Cancer Chemotherapy and Pharmacology Gastrointestinal Peptide HormoneMedicineGastroenterologyPathologyDigestive Tract	2007	13

Page 1